PROTECTIVE EFFECT OF CREATINE AGAINST 6-HYDROXYDOPAMINE-INDUCED CELL DEATH IN HUMAN NEUROBLASTOMA SH-SY5Y CELLS: INVOLVEMENT OF INTRACELLULAR SIGNALING PATHWAYS

被引:36
作者
Cunha, M. P. [1 ,2 ,4 ]
Martin-de-Saavedra, M. D. [1 ,2 ]
Romero, A. [1 ,2 ,5 ]
Parada, E. [1 ,2 ]
Egea, J. [1 ,2 ,3 ]
del Barrio, L. [1 ,2 ]
Rodrigues, A. L. S. [4 ]
Lopez, M. G. [1 ,2 ,3 ]
机构
[1] Univ Autonoma Madrid, Fac Med, Inst Teofilo Hernando, E-28029 Madrid, Spain
[2] Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, E-28029 Madrid, Spain
[3] Hosp Princesa, Inst Invest Sanitaria, Madrid, Spain
[4] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Bioquim, BR-88040900 Florianopolis, SC, Brazil
[5] Univ Complutense Madrid, Fac Vet, Dept Toxicol & Farmacol, E-28040 Madrid, Spain
关键词
6-OHDA; AKT; creatine; GSK-3; beta; neuroprotection; PKA; PROTEIN-KINASE-C; GLYCOGEN-SYNTHASE KINASE-3; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL; 3-KINASE; PHOSPHOINOSITIDE; HEME OXYGENASE-1; IN-VITRO; ACTIVATION;
D O I
10.1016/j.neuroscience.2013.02.030
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The guanidine-like compound creatine exerts bioenergetic, antiexcitotoxic, antioxidant and neuroprotective properties; however, the intracellular mechanisms responsible for these effects are still not well established. The purpose of this study was to investigate the protective effect of creatine against 6-hydroxydopamine (6-OHDA)-induced cell death in neuroblastoma SH-SY5Y cells and the possible intracellular signaling pathways involved in such effect. Exposure of SH-SY5Y cells to 100-300 mu M of 6-OHDA for 24 h caused a significant concentration-dependent cell death measured as a diminution of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT) reduction and as an increase in the extracellular release of lactate dehydrogenase. SH-SY5Y cells incubated for 24 or 48 h with creatine (10-5000 mu M) was not cytotoxic. However, pre and co-treatment with creatine (0.3-1000 mu M) for 24 h reduced 6-OHDA-induced toxicity. The protective effect afforded by creatine against 6-OHDA-induced toxicity was reversed by inhibitors of different protein kinases, i.e. phosphatidylinositol-3 kinase (PI3K) (LY294002), Ca2+/calmodulin-dependent protein kinase II (CaMKII) (KN-93), protein kinase A (H-89), mitogen-activated protein kinase kinase 1/2 (MEK1/2) (PD98059) and protein kinase C (PKC) (chelerythrine). Furthermore, creatine prevented the 6-OHDA-induced dephosphorylation of glycogen synthase kinase-3 beta (GSK-3 beta) at the serine 9 residue. In conclusion, the results of this study show that creatine can protect against 6-OHDA-induced toxicity and its protective mechanism is related to a signaling pathway that involves PI3K, PKC, PKA, CaMKII, MEK1/2 and GSK-3 beta. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:185 / 194
页数:10
相关论文
共 91 条
[1]   Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system [J].
Andres, RH ;
Ducray, AD ;
Pérez-Bouza, A ;
Schlattner, U ;
Huber, AW ;
Krebs, SH ;
Seiler, RW ;
Wallimann, T ;
Widmer, HR .
CELL TRANSPLANTATION, 2005, 14 (08) :537-550
[2]   Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue [J].
Andres, RH ;
Huber, AW ;
Schlattner, U ;
Pérez-Bouza, A ;
Krebs, SH ;
Seiler, RW ;
Wallimann, T ;
Widmer, HR .
NEUROSCIENCE, 2005, 133 (03) :701-713
[3]   Effect of Oxytocin on Neuroblastoma Cell Viability and Growth [J].
Bakos, Jan ;
Strbak, Vladimir ;
Ratulovska, Nina ;
Bacova, Zuzana .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2012, 32 (05) :891-896
[4]   Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease [J].
Beal, M. Flint .
PARKINSONISM & RELATED DISORDERS, 2009, 15 :S189-S194
[5]   Prevention of neuronal apoptosis by phorbol ester-induced activation of protein kinase C: Blockade of p38 mitogen-activated protein kinase [J].
Behrens, MM ;
Strasser, U ;
Koh, JY ;
Gwag, BJ ;
Choi, DW .
NEUROSCIENCE, 1999, 94 (03) :917-927
[6]   Creatine supplementation in Parkinson disease:: A placebo-controlled randomized pilot trial [J].
Bender, A. ;
Koch, W. ;
Elstner, M. ;
Schombacher, Y. ;
Bender, J. ;
Moeschl, M. ;
Gekeler, F. ;
Mueller-Myhsok, B. ;
Gasser, T. ;
Tatsch, K. ;
Klopstock, T. .
NEUROLOGY, 2006, 67 (07) :1262-1264
[7]   TRANSPORT OF ENERGY IN MUSCLE - THE PHOSPHORYLCREATINE SHUTTLE [J].
BESSMAN, SP ;
GEIGER, PJ .
SCIENCE, 1981, 211 (4481) :448-452
[8]  
Blandini Fabio, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS124, DOI 10.1016/j.parkreldis.2008.04.015
[9]   The role of CREB in depression and antidepressant treatment [J].
Blendy, JA .
BIOLOGICAL PSYCHIATRY, 2006, 59 (12) :1144-1150
[10]  
Bloom Marlene Z, 2007, Consult Pharm, V22, P378